Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J. H. Bentley"'
Autor:
B. Terrier, D. Jayne, B. Hellmich, J. H. Bentley, J. Steinfeld, S. W. Yancey, N. Kwon, P. Akuthota, P. Khoury, L. Baylis, M. Wechsler
Publikováno v:
Annals of the Rheumatic Diseases. 81:709-709
BackgroundPatients with eosinophilic granulomatosis with polyangiitis (EGPA) can present with vasculitic or eosinophilic phenotypes.1 The Phase III MIRRA study demonstrated that patients with EGPA spent more time in remission and had reduced oral cor
Publikováno v:
The American journal of cardiology. 87(5)
We observed in a study of 7,651 patients with acute coronary syndromes that a white blood cell (WBC) count of10,000 was associated with increased 30-day and 10-month mortality (6.2% vs 3.2% to 3.6% for WBC count10,000; p0.000). With its simplicity an
Autor:
H. K. Hall, J H Bentley
Publikováno v:
Polymer Bulletin. 3:203-210
7,7,8,8-Tetra-(methoxycarbonyl)-quinodimethane, TMQ, was synthesized in improved yield from tetramethyl p-phenylenedimalonate by forming the dianion of the latter with potassium hydride and oxidizing it with iodine. Free radical and anionic initiator
Publikováno v:
Oncology nursing forum. 15(2)
Autor:
J. H. Bentley, C. Heygate Vernon, C. E. P. Markby, Thomas Robson, Humphrey I. Marriner, J. W. Nankivell, A. Basil Rooke, D. D. Malpas
Publikováno v:
The Lancet. 241:663
Autor:
J. H. Bentley, J. W. Nankivell, A. Basil Rooke, D. D. Malpas, C. E. P. Markby, Humphrey I. Marriner, Thomas Robson
Publikováno v:
BMJ. 1:649-649
Autor:
Amy D. Klion, Florence Roufosse, Marc E. Rothenberg, Suyong Yun Kirby, Jane H Bentley, Jonathan Steinfeld, Martyn J. Gilson, Eric S. Bradford, Steven W. Yancey, Andrew J. Wardlaw, Jean-Emmanuel Kahn, Gerald J. Gleich
Publikováno v:
Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2020, 146 (6), pp.1397-1405. ⟨10.1016/j.jaci.2020.08.037⟩
Journal of allergy and clinical immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2020, 146 (6), pp.1397-1405. ⟨10.1016/j.jaci.2020.08.037⟩
Journal of allergy and clinical immunology
Background: Anti–IL-5 therapy is a potential treatment for patients with hypereosinophilic syndrome (HES), although its clinical efficacy is unclear. Objective: We sought to investigate the clinical efficacy and safety of mepolizumab versus placebo